Journal article

Fructose-1,6-bisphosphatase overexpression in pancreatic β-cells results in reduced insulin secretion: A new mechanism for fat-induced impairment of β-cell function

M Kebede, J Favaloro, JE Gunton, DR Laybutt, M Shaw, N Wong, BC Fam, K Aston-Mourney, C Rantzau, A Zulli, J Proietto, S Andrikopoulos

Diabetes | AMER DIABETES ASSOC | Published : 2008

Open access

Abstract

OBJECTIVE-Fructose-1,6-bisphosphatase (FBPase) is a gluconeogenic enzyme that is upregulated in islets or pancreatic β-cell lines exposed to high fat. However, whether specific β-cell upregulation of FBPase can impair insulin secretory function is not known. The objective of this study therefore is to determine whether a specific increase in islet β-cell FBPase can result in reduced glucose-mediated insulin secretion. RESEARCH DESIGN AND METHODS-To test this hypothesis, we have generated three transgenic mouse lines overexpressing the human FBPase (huFBPase) gene specifically in pancreatic islet β-cells. In addition, to investigate the biochemical mechanism by which elevated FBPase affects i..

View full abstract